EA200100107A1 - Новые 2,3,3a,4,9,9a-гексагидро-8-гидрокси-1h-бенз[f]индолы, способ их получения и их применение в качестве лекарственных средств - Google Patents
Новые 2,3,3a,4,9,9a-гексагидро-8-гидрокси-1h-бенз[f]индолы, способ их получения и их применение в качестве лекарственных средствInfo
- Publication number
- EA200100107A1 EA200100107A1 EA200100107A EA200100107A EA200100107A1 EA 200100107 A1 EA200100107 A1 EA 200100107A1 EA 200100107 A EA200100107 A EA 200100107A EA 200100107 A EA200100107 A EA 200100107A EA 200100107 A1 EA200100107 A1 EA 200100107A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- benz
- hexahydro
- hydroxy
- preparation
- indols
- Prior art date
Links
- RTZRFZYJESSGKB-UHFFFAOYSA-N 2,3,3a,4,9,9a-hexahydro-1h-benzo[f]indol-8-ol Chemical compound C1C2CCNC2CC2=C1C=CC=C2O RTZRFZYJESSGKB-UHFFFAOYSA-N 0.000 abstract 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002475 indoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
В заявке описаны замещенные производные 2,3,3a,4,9,9a-гексагидро-8-гидрокси-1H-бенз[f]индола, способ их получения, а также их применение в качестве лекарственных средств. Производные индола согласно изобретению соответствуют общей формуле (1).Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19834714A DE19834714A1 (de) | 1998-07-31 | 1998-07-31 | Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
PCT/EP1999/005222 WO2000007986A1 (de) | 1998-07-31 | 1999-07-22 | Neue 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1h-benz[f]indole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200100107A1 true EA200100107A1 (ru) | 2001-08-27 |
EA003370B1 EA003370B1 (ru) | 2003-04-24 |
Family
ID=7876092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200100107A EA003370B1 (ru) | 1998-07-31 | 1999-07-22 | Новые 2,3,3a,4,9,9a-гексагидро-8-гидрокси-1h-бенз[f]индолы, способ их получения и их применение в качестве лекарственных средств |
Country Status (30)
Country | Link |
---|---|
US (1) | US6051583A (ru) |
EP (1) | EP1100780B1 (ru) |
JP (1) | JP2002522418A (ru) |
KR (1) | KR20010072142A (ru) |
CN (1) | CN1147470C (ru) |
AT (1) | ATE360611T1 (ru) |
AU (1) | AU763834B2 (ru) |
BG (1) | BG105178A (ru) |
BR (1) | BR9912605A (ru) |
CA (1) | CA2336783C (ru) |
CO (1) | CO5080748A1 (ru) |
DE (2) | DE19834714A1 (ru) |
EA (1) | EA003370B1 (ru) |
EE (1) | EE200100062A (ru) |
ES (1) | ES2285851T3 (ru) |
HK (1) | HK1038017A1 (ru) |
HU (1) | HUP0103518A3 (ru) |
ID (1) | ID28292A (ru) |
IL (1) | IL140863A0 (ru) |
MY (1) | MY133085A (ru) |
NO (1) | NO20010513L (ru) |
NZ (1) | NZ510246A (ru) |
PL (1) | PL345808A1 (ru) |
SK (1) | SK1502001A3 (ru) |
TR (1) | TR200100316T2 (ru) |
TW (1) | TW464643B (ru) |
UA (1) | UA68388C2 (ru) |
WO (1) | WO2000007986A1 (ru) |
YU (1) | YU5501A (ru) |
ZA (1) | ZA200007770B (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0002666D0 (en) | 2000-02-04 | 2000-03-29 | Univ London | Blockade of voltage dependent sodium channels |
ATE359783T1 (de) * | 2001-12-27 | 2007-05-15 | Ortho Mcneil Pharm Inc | Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0482084B1 (en) * | 1989-07-13 | 1997-05-07 | PHARMACIA & UPJOHN COMPANY | (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives |
JPH06507906A (ja) * | 1991-05-20 | 1994-09-08 | ジ・アップジョン・カンパニー | カルボキサミド−(3,2n)−カルボサイクリック−2−アミノテトラリン誘導体 |
GB9612153D0 (en) * | 1996-06-11 | 1996-08-14 | Smithkline Beecham Plc | Compounds |
-
1998
- 1998-07-31 DE DE19834714A patent/DE19834714A1/de not_active Ceased
-
1999
- 1999-07-22 WO PCT/EP1999/005222 patent/WO2000007986A1/de active IP Right Grant
- 1999-07-22 BR BR9912605-2A patent/BR9912605A/pt not_active IP Right Cessation
- 1999-07-22 EE EEP200100062A patent/EE200100062A/xx unknown
- 1999-07-22 NZ NZ510246A patent/NZ510246A/en unknown
- 1999-07-22 DE DE59914314T patent/DE59914314D1/de not_active Expired - Fee Related
- 1999-07-22 UA UA2001021382A patent/UA68388C2/uk unknown
- 1999-07-22 JP JP2000563620A patent/JP2002522418A/ja active Pending
- 1999-07-22 YU YU5501A patent/YU5501A/sh unknown
- 1999-07-22 ID IDW20010244A patent/ID28292A/id unknown
- 1999-07-22 PL PL99345808A patent/PL345808A1/xx not_active Application Discontinuation
- 1999-07-22 EA EA200100107A patent/EA003370B1/ru not_active IP Right Cessation
- 1999-07-22 AT AT99936584T patent/ATE360611T1/de not_active IP Right Cessation
- 1999-07-22 CN CNB998089702A patent/CN1147470C/zh not_active Expired - Fee Related
- 1999-07-22 CA CA002336783A patent/CA2336783C/en not_active Expired - Fee Related
- 1999-07-22 EP EP99936584A patent/EP1100780B1/de not_active Expired - Lifetime
- 1999-07-22 TR TR2001/00316T patent/TR200100316T2/xx unknown
- 1999-07-22 AU AU51626/99A patent/AU763834B2/en not_active Ceased
- 1999-07-22 SK SK150-2001A patent/SK1502001A3/sk unknown
- 1999-07-22 ES ES99936584T patent/ES2285851T3/es not_active Expired - Lifetime
- 1999-07-22 KR KR1020017001334A patent/KR20010072142A/ko not_active Application Discontinuation
- 1999-07-22 IL IL14086399A patent/IL140863A0/xx unknown
- 1999-07-22 HU HU0103518A patent/HUP0103518A3/hu unknown
- 1999-07-29 TW TW088112896A patent/TW464643B/zh not_active IP Right Cessation
- 1999-07-29 MY MYPI99003229A patent/MY133085A/en unknown
- 1999-07-30 CO CO99048374A patent/CO5080748A1/es unknown
- 1999-07-30 US US09/365,064 patent/US6051583A/en not_active Expired - Lifetime
-
2000
- 2000-12-21 ZA ZA200007770A patent/ZA200007770B/en unknown
-
2001
- 2001-01-24 BG BG105178A patent/BG105178A/xx active Pending
- 2001-01-30 NO NO20010513A patent/NO20010513L/no not_active Application Discontinuation
- 2001-12-19 HK HK01108875A patent/HK1038017A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200200873A1 (ru) | Новые пиперазиновые производные | |
EA200000759A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
EA200001224A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
EA199900494A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
EA200001223A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
FI963169A (fi) | Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia | |
EA200100524A1 (ru) | Амиды антраниловой кислоты и их применение в качестве лекарственных средств | |
EA200300873A1 (ru) | Новая соль сукцинат o-десметилвенлафаксина | |
EA200100826A1 (ru) | 16-галогенопроизводные эпотилона, способ их получения и их применение в фармацевтике | |
EA200201271A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
BR0008056A (pt) | Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas | |
EA199900598A1 (ru) | Производные 1-арил- и пиридилпиразола с пестицидными свойствами | |
EA200000592A1 (ru) | Азаполициклические соединения, конденсированные с арилом | |
EA199900620A1 (ru) | Фталазиноны | |
EA199900278A1 (ru) | Модифицированные аминокислоты, содержащие эти соединения лекарственные средства и способ их получения | |
EA200200479A1 (ru) | Новые олигосахариды, их получение и содержащие их фармацевтические композиции | |
EA199900279A1 (ru) | Производные бензамида и их применение в качестве лекарственных средств с лтв4-антагонистической активностью | |
ATE233274T1 (de) | Oxyiminopregnancarbolactone | |
EA200100012A1 (ru) | Мостиковые инденопирролокарбазолы | |
EA200301223A1 (ru) | Лекарственные формы окскарбазепина | |
EA199700253A1 (ru) | Производные нодулиспоровой кислоты | |
EA199700380A1 (ru) | Бициклические ароматические соединения, фармацевтическая и косметическая композиции на их основе и применение косметической композиции | |
EA199700160A1 (ru) | Производные индола в качестве антагонистов eaa | |
EA200200096A1 (ru) | Новые производные витамина d с циклическими субструктурами в боковых цепях, способ и промежуточные продукты для их получения и их применение для получения лекарственных средств | |
EA200000094A1 (ru) | Способ получения замещенного пергидроизоиндола |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |